How do you monitor for cardiac toxicity in patients taking osimertinib?
2
1 Answers
Mednet Member
Medical Oncology · University of Colorado Anschutz Medical Center
There are multiple studies that have explored the issue of cardiotoxicity from osimertinib. A large single-center retrospective observational cohort series from Taiwan, (n=401) compared a matched cohort of patients treated with osimertinib (n=253) to those treated with other EGFR TKIs (n=195) and fo...